Publications by authors named "Behrooz Gharib"

Claim this Profile
P
Pharmaceutical and clinical studies of celecoxib topical hydrogel for management of chemotherapy-induced hand-foot syndrome.
Delaram Shayeganmehr, Fatemeh Ramezannia, Behrooz Gharib, Azin Rezaeilaal, Farhad Shahi

Naunyn Schmiedebergs Arch Pharmacol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Comparing efficacy and safety of P013, a proposed pertuzumab biosimilar, with the reference product in HER2-positive breast cancer patients: a randomized, phase III, equivalency clinical trial.
Abolghasem Allahyari, Ali Ehsanpour, Behrouz Najafi, Nafseh Ansarinejad, Valiollah Mehrzad, Behrooz Gharib, Sirus Gharib

BMC Cancer· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
'
'Harlequin cells' in lymphocyte-variant hypereosinophilia.
Amirali Vahedi, Tahereh Madani, Behrooz Gharib, Behzad Poopak

EJHaem· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing efficacy and safety of P013, a proposed pertuzumab biosimilar, with the reference product in HER2-positive breast cancer patients: a randomized, phase III, equivalency clinical trial.
Abolghasem Allahyari, Ali Ehsanpour, Behrouz Najafi, Nafiseh Ansarinejad, Valiollah Mehrzad, Behrooz Gharib, Sirus Gharib

BMC Cancer· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, double-blind, placebo-controlled investigation of BCc1 nanomedicine effect on survival and quality of life in metastatic and non-metastatic gastric cancer patients.
Maryam Hafizi, Somayeh Kalanaky, Hassan Moaiery, Maryam Khayamzadeh, Sajad Noorian, Behrooz Gharib

J Nanobiotechnology· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis